Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap5.87B
EV5.87B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
60.5
68.2
77.8
105.0
153.1
159.3
186.3
228.2
261.0
263.0
Revenue % Chg.
3.8%
12.7%
14.0%
34.9%
45.8%
4.1%
16.9%
22.5%
14.4%
17.6%
Cost of Revenue
31.7
30.0
39.5
42.0
39.8
43.6
67.5
82.0
85.4
85.0
Gross Profit
28.8
38.2
38.3
63.0
113.3
115.7
118.7
146.2
175.6
178.0
Gross Profit Margin
47.7%
56.0%
49.3%
60.0%
74.0%
72.6%
63.7%
64.1%
67.3%
67.7%
R&D Expenses
1.8
2.3
1.9
3.1
6.2
6.0
7.8
7.5
10.3
10.4
Selling, General, & Admin Expenses
7.3
12.8
14.1
35.2
80.1
82.0
75.2
96.5
116.0
115.0
Other Expenses
6.0
8.3
10.4
11.2
11.2
12.9
17.9
21.3
18.7
19.9
Operating Income
13.8
14.9
12.0
13.6
15.9
14.0
15.0
14.5
48.4
51.1
Operating Income Margin
22.7%
21.8%
15.4%
12.9%
10.4%
8.8%
8.1%
6.4%
18.5%
19.4%
Total Other Income/Expenses Net
0.9
1.8
0.9
-1.9
-2.4
-0.3
-5.0
-1.3
-0.8
1.8
Income Before Tax
14.7
16.7
12.9
11.7
13.4
13.8
10.0
13.2
47.6
52.9
Income Before Tax Margin
24.3%
24.5%
16.6%
11.1%
8.8%
8.6%
5.4%
5.8%
18.2%
20.1%
Income Tax Expense
2.2
2.6
2.2
2.3
1.8
2.3
2.2
3.0
7.3
8.0
Net Income
11.8
13.2
10.2
8.7
10.6
11.5
9.3
10.2
41.6
45.7
Net Income Margin
19.5%
19.4%
13.1%
8.3%
6.9%
7.2%
5.0%
4.5%
16.0%
17.4%
Weighted Avg. Shares Out
329.0
425.0
436.0
426.3
429.4
415.3
425.3
437.8
433.1
429.2
EPS
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
EPS % Chg.
6.7%
-13.3%
-25.0%
-12.5%
21.4%
11.8%
-21.1%
6.7%
312.5%
226.6%
Weighted Avg. Shares Out Dil
329.0
425.0
436.0
426.3
429.4
438.4
425.3
437.8
433.1
429.2
EPS Diluted
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
Interest Income
0.3
0.8
1.1
0.8
1.2
1.1
0.5
0.3
-0.7
-1.0
Interest Expense
0.3
0.8
0.1
0.7
0.8
1.6
2.5
2.7
3.3
2.8
EBIT
14.7
16.7
13.9
11.8
13.9
13.2
8.1
10.8
43.5
49.0
EBIT Margin
24.3%
24.5%
17.9%
11.3%
9.1%
8.3%
4.4%
4.7%
16.7%
18.6%
Depreciation & Amortization
2.2
2.9
4.0
5.4
6.4
10.9
10.3
15.2
17.6
7.3
EBITDA
16.9
19.6
17.9
17.2
20.3
24.2
18.4
26.0
61.1
56.4
EBITDA Margin
28.0%
28.7%
23.0%
16.4%
13.3%
15.2%
9.9%
11.4%
23.4%
21.4%